Codexis (CDXS) Research & Development (2010 - 2026)
Codexis (CDXS) recorded quarterly Research & Development of $11.4 million in Q1 2026, down 2.33% quarter-over-quarter from $11.7 million in Q4 2025, and down 11.54% on a YoY basis from $12.9 million in Q1 2025.
Codexis (CDXS) Research & Development (2010 - 2026) Analysis & Trends
Codexis' Research & Development history runs 17 years deep, the most recent figure standing at $11.4 million for Q1 2026.
- In Q1 2026, Research & Development fell 11.54% year-over-year to $11.4 million; the TTM figure through Mar 2026 stood at $50.8 million (up 5.95% YoY), while the FY2025 annual figure was $52.3 million, up 13.06% from the prior year.
- Research & Development was $11.4 million for Q1 2026 at Codexis, down from $11.7 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $21.8 million in Q3 2022 to a low of $11.2 million in Q4 2023.
- Historically, Research & Development has averaged $14.6 million across 5 years, with a median of $13.7 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Research & Development soared 68.52% in 2022, then sank 42.94% in 2023.
- A 5-year view of Research & Development shows it stood at $19.7 million in 2022, then plunged by 42.94% to $11.2 million in 2023, then climbed by 7.7% to $12.1 million in 2024, then dropped by 3.12% to $11.7 million in 2025, then retreated by 2.33% to $11.4 million in 2026.
- The last three Research & Development figures came in at $11.4 million (Q1 2026), $11.7 million (Q4 2025), and $13.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -58.00 Mn |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | 11.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.45 Mn |
| Dec 31, 2025 | 11.72 Mn |
| Sep 30, 2025 | 13.87 Mn |
| Jun 30, 2025 | 13.78 Mn |
| Mar 31, 2025 | 12.94 Mn |
| Dec 31, 2024 | 12.10 Mn |
| Sep 30, 2024 | 11.51 Mn |
| Jun 30, 2024 | 11.41 Mn |
| Mar 31, 2024 | 11.25 Mn |
| Dec 31, 2023 | 11.23 Mn |
| Sep 30, 2023 | 13.66 Mn |
| Jun 30, 2023 | 17.33 Mn |
| Mar 31, 2023 | 16.66 Mn |
| Dec 31, 2022 | 19.69 Mn |
| Sep 30, 2022 | 21.82 Mn |
| Jun 30, 2022 | 19.09 Mn |
| Mar 31, 2022 | 19.50 Mn |
| Dec 31, 2021 | 16.36 Mn |
| Sep 30, 2021 | 15.17 Mn |
| Jun 30, 2021 | 12.83 Mn |